Ann Marie Mauer to Protein Kinase Inhibitors
This is a "connection" page, showing publications Ann Marie Mauer has written about Protein Kinase Inhibitors.
Connection Strength
0.115
-
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11.
Score: 0.060
-
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib. J Thorac Oncol. 2007 May; 2(5):414-22.
Score: 0.055